Condition: COVID-19 Respiratory Infection · Sponsor: University Hospital Hradec Kralove
Patients requiring admission to the hospital due to a moderate and severe COVID-19 infection may differ in their ability to respond to viral infection and to eliminate viral load. Several comorbidities and interventions like antivirotic or antiinflammatory treatment may also modify expected patients response and decrease of viral load. In this observational study, evolution of selected inflammatory markers, indicators of severity of infection and patient characteristics will be followed and recorded in hospitalized patients with COVID-19.
This description comes directly from the study's public registry record.
Pavel Dostál, MD, PhD · +420602455632 · pavel.dostal@fnhk.cz
Vladimir Koblizek, MD, Ph.D. · +420723448641 · vladimir.koblizek@fnhk.cz
Always discuss trial participation with your own doctor first.
| University Hospital Hradec Kralove | Hradec Králové, Czechia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04887623